SC 13G 1 sc13g.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

INVO Bioscience, Inc.

(Name of Issuer)

Common Stock, par value of $0.0001 per share

(Title of Class of Securities)

44984F302

(CUSIP Number)

December 31, 2021

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☐ Rule 13d-1(c)

☐ Rule 13d-1(d)

^*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 44984F302

13G

Page 2 of 5 Pages

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Claude Jean Ranoux
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION United States

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

766,189

SHARED VOTING POWER

SOLE DISPOSITIVE POWER

766,189

SHARED DISPOSITIVE POWER

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 766,189
10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.53%
12.	TYPE OF REPORTING PERSON (see instructions) IN

CUSIP No. 44984F302

13G

Page 3 of 5 Pages

Item 1.

(a)

Name of Issuer

INVO Bioscience, Inc.

(b)

Address of Issuer’s Principal Executive Offices

5582 Broadcast Court

Sarasota, Florida 34240

Item 2.

	(a)	Name of Person Filing Claude Jean Ranoux

	(b)	Address of the Principal Office or, if none, residence 8 Chestnut St. Winchester, MA 01890

	(c)	Citizenship United States

	(d)	Title of Class of Securities Common stock, par value $0.0001 per share.

	(e)	CUSIP Number CUSIP number 44984F104 has been assigned to the shares of common stock of the Issuer, which are quoted on the Nasdaq Global Select Market under the symbol “INVO.”

Item 3.

Not applicable.

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a) Amount beneficially owned:

766,189

(b) Percent of class:

6.53%

CUSIP No. 44984F302

13G

Page 4 of 5 Pages

(c) Number of shares as to which the person has:

	(i)	Sole power to vote or to direct the vote
		766,189

	(ii)	Shared power to vote or to direct the vote
		0

	(iii)	Sole power to dispose or to direct the disposition of
		766,189

	(iv)	Shared power to dispose or to direct the disposition of
		0

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of Group.

Not applicable.

Item 10. Certification.

Not applicable.

CUSIP No. 44984F302

13G

Page 5 of 5 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	February 22, 2022
	Date

	/s/ Claude Jean Ranoux
	Claude Jean Ranoux

SEC Form SC 13G filed by INVO BioScience Inc.